Trial Profile
Pergolide treatment and valvular heart disease
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Mar 2008
Price :
$35
*
At a glance
- Drugs Cabergoline (Primary) ; Pergolide (Primary) ; Pramipexole (Primary) ; Ropinirole (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions
- Acronyms PERMAX
- 24 Mar 2008 New trial record.